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abstract
 
The antiarrhythmic agent ﬂecainide appears beneﬁcial for painful congenital myotonia and LQT-3/
 
 
 
KPQ syndrome. Both diseases manifest small but persistent late Na
 
 
 
 currents in skeletal or cardiac myocytes.
Flecainide may therefore block late Na
 
 
 
 currents for its efﬁcacy. To investigate this possibility, we characterized
state-dependent block of ﬂecainide in wild-type and inactivation-deﬁcient rNav1.4 muscle Na
 
 
 
 channels (L435W/
L437C/A438W) expressed with 
 
 
 
1 subunits in Hek293t cells. The ﬂecainide-resting block at 
 
 
 
140 mV was weak
for wild-type Na
 
 
 
 channels, with an estimated 50% inhibitory concentration (IC
 
50
 
) of 365 
 
 
 
M when the cell was
not stimulated for 1,000 s. At 100 
 
 
 
M ﬂecainide, brief monitoring pulses of 
 
 
 
30 mV applied at frequencies as low
as 1 per 60 s, however, produced an 
 
 
 
70% use-dependent block of peak Na
 
 
 
 currents. Recovery from this use-
dependent block followed an exponential function, with a time constant over 225 s at 
 
 
 
140 mV. Inactivated wild-
type Na
 
 
 
 channels interacted with ﬂecainide also slowly at 
 
 
 
50 mV, with a time constant of 7.9 s. In contrast,
ﬂecainide blocked the open state of inactivation-deﬁcient Na
 
 
 
 channels potently as revealed by its rapid time-
dependent block of late Na
 
 
 
 currents. The IC
 
50
 
 for ﬂecainide open-channel block at 
 
 
 
30 mV was 0.61 
 
 
 
M, right
within the therapeutic plasma concentration range; on-rate and off-rate constants were 14.9 
 
 
 
M
 
 
 
1
 
s
 
 
 
1
 
 and 12.2 s
 
 
 
1
 
,
respectively. Upon repolarization to 
 
 
 
140 mV, ﬂecainide block of inactivation-deﬁcient Na
 
 
 
 channels recovered,
with a time constant of 11.2 s, which was 
 
 
 
20-fold faster than that of wild-type counterparts. We conclude that
ﬂecainide directly blocks persistent late Na
 
 
 
 currents with a high afﬁnity. The fast-inactivation gate, probably via
its S6 docking site, may further stabilize the ﬂecainide-receptor complex in wild-type Na
 
 
 
 channels.
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INTRODUCTION
 
Flecainide is one of class Ic antiarrhythmic drugs taken
orally (Roden, 2001). Use of ﬂecainide is limited to pa-
tients with supraventricular arrhythmia, as this drug is
also proarrhythmic. The primary target of ﬂecainide is
the cardiac voltage–gated Na
 
 
 
 channel, which is re-
sponsible for the upstroke of cardiac action potentials.
Interestingly, the severely affected family member with
painful congenital myotonia responded dramatically to
ﬂecainide treatment (Rosenfeld et al., 1997). Flecain-
ide has also been found to be effective for patients with
Long QT-3 syndromes (e.g., LQT-3/
 
 
 
KPQ; Windle et
al., 2001). These new therapeutic applications of ﬂecain-
ide give rise to a renewed interest in studying its action
on voltage-gated Na
 
 
 
 channels (e.g., Nagatomo et al.,
2000; Viswanathan et al., 2001).
The Na
 
 
 
 channel 
 
 
 
-subunit isoforms consist of four
repeated domains (D1–D4), each with six transmem-
brane segments (S1–S6). The receptors for ﬂecainide
and for traditional local anesthetics (LAs) were found
to share common structural determinants at the D4S6
segment of Na
 
 
 
 channel 
 
 
 
-subunit (Ragsdale et al.,
1996). Like LAs, ﬂecainide appears to have a higher af-
ﬁnity for activated Na
 
 
 
 channels than for resting coun-
terparts, as originally suggested by Anno and Honde-
ghem (1990) and Nitta et al. (1992). Flecainide also
elicits strong use-dependent block during repetitive
pulses. This phenotype was examined recently by Liu
et al. (2002) using Nav1.5 mutants related to LQT-3
and Brugada syndromes. These authors suggested that
ﬂecainide interacts primarily with inactivated states of
Na
 
 
 
 channels.
Flecainide apparently blocks persistent late currents
more effectively than it blocks peak currents in mu-
tations associated with painful congenital myotonia
(Wang et al., 1999) and with LQT-3/
 
 
 
KPQ syndrome
(Nagatomo et al., 2000). Repetitive pulses elicit addi-
tional use-dependent block of peak and late currents
by ﬂecainide. The IC
 
50
 
 values of peak and late currents
for the wild-type were 127 and 44 
 
 
 
M, respectively, and
were 80 and 19 
 
 
 
M, respectively, for LQT-3/
 
 
 
KPQ.
However, because of their small amplitudes, it was
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Abbreviations used in this paper:
 
 HEK, human embryonic kidney; LA, lo-
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 Currents
 
rather difﬁcult to characterize persistent late Na
 
 
 
 cur-
rents in these mutants. To increase persistent late cur-
rents, Grant et al. (2000) used inactivation-deﬁcient
Nav1.5 Na
 
 
 
 channels with mutations at the IFM motif
(IFM
 
→
 
QQQ) and found that the use-dependent block
of ﬂecainide remains in these mutant channels. The
IFM motif is critical for normal fast inactivation and is
situated at the cytoplasmic D3-D4 linker, which may
function as an inactivation gate (West et al., 1992). The
extrapolated ﬂecainide K
 
D
 
 value for the noninactivat-
ing currents was 27.6 
 
 
 
M. The clinical relevance of
these relatively high IC
 
50
 
 and K
 
D
 
 values remains un-
clear, as the therapeutic plasma concentration of
ﬂecainide is in a range of 0.4 to 2 
 
 
 
M (Viswanathan et
al., 2001).
In this study we sought to address the state-depen-
dent binding of ﬂecainide in wild-type and rNav1.4-
L435W/L437C/A438W inactivation-deﬁcient rat-muscle
Na
 
 
 
 channels. Residues of L435/L437/A438 are lo-
cated at the COOH terminus of D1S6, which is differ-
ent from the IFM locus. We chose this inactivation-deﬁ-
cient rNav1.4 mutant because it expressed well in the
Hek293t expression system (Wang et al., 2003), unlike
the inactivation-deﬁcient hNav1.5 IFM/QQQ mutant
(Grant et al., 2000). Our results demonstrate that
ﬂecainide binds rapidly and preferentially with the
open state but weakly with the resting state. Once the
channel is blocked by ﬂecainide, the inactivation gate
may stabilize ﬂecainide binding in situ.
 
MATERIALS AND METHODS
 
Site-directed Mutagenesis
 
We used the QuikChange XL site-directed mutagenesis kit (Strat-
agene) to create rat skeletal muscle Nav1.4 mutant clones (Wang et
al., 2003). To minimize the possibility that unique phenotypes are
due to unwanted mutations, we also created independent clones of
rNav1.4-L435W/L437C/A438W, rNav1.4-L437C/A438W, and ho-
mologous clones in human isoforms (hNav1.4 and hNav1.5).
These independent and homologous clones displayed phenotypes
similar to those of their rNav1.4 counterparts (Wang et al., 2003).
Furthermore, ﬂecainide block in these inactivation-deﬁcient mu-
tant isoforms appeared comparable in our preliminary studies.
 
Transient Transfection
 
Human embryonic kidney cells (HEK293t) were grown to 
 
 
 
50%
conﬂuence in DMEM (GIBCO BRL) containing 10% fetal bo-
vine serum (HyClone), 1% penicillin and streptomycin solution
(Sigma-Aldrich), 3 mM taurine, and 25 mM HEPES (GIBCO
BRL) and then transfected by a calcium phosphate precipita-
tion method (Cannon and Strittmatter, 1993). Transfection of
rNav1.4-pcDNA1/Amp or mutant clones (5–10 
 
 
 
g) along with
 
 
 
1 (10–20 
 
 
 
g) and reporter CD8-pih3m (1 
 
 
 
g) was adequate for
current recording. Cells were replated 15 h after transfection in
35-mm dishes, maintained at 37
 
 
 
C in a 5% CO
 
2
 
 incubator, and
used after 1–4 d. Transfection-positive cells were identiﬁed with
immunobeads (CD8-Dynabeads).
 
Whole-cell Voltage Clamp
 
Whole-cell conﬁguration was used to record Na
 
 
 
 currents (Hamill
et al., 1981). Borosilicate micropipettes (Drummond Scientiﬁc
Company) were pulled with a puller (P-87; Sutter Instrument Co.)
and heat polished. Pipette electrodes contained 100 mM NaF, 30
mM NaCl, 10 mM EGTA, and 10 mM HEPES adjusted to pH 7.2
with CsOH. The pipette electrodes had a tip resistance of 0.5–1.0
M
 
 
 
. Access resistance was 1–2 M
 
 
 
 and was further reduced by se-
ries resistance compensation. All experiments were performed at
room temperature (22–24
 
 
 
C) under a Na
 
 
 
-containing bath solu-
tion with 65 mM NaCl, 85 mM choline Cl, 2 mM CaCl
 
2
 
, and 10
mM HEPES adjusted to pH 7.4 with tetramethyl-ammonium hy-
droxide. Flecainide acetate was purchased from Sigma-Aldrich
and dissolved in DMSO solution at 100 mM as stock solution. Final
ﬂecainide concentrations were prepared from stock by serial dilu-
tion with bath solution. Whole-cell currents were measured by an
Axopatch 200B (Axon Instruments, Inc.) or an EPC-7 (List Elec-
Figure 1. Families of superimposed Na  current traces before and after 30  M ﬂecainide application. Currents were evoked by 5-ms
pulses to voltages ranging from  120 to  50 mV in 10-mV increments and were recorded before (A) and after 30  M ﬂecainide (B). The
inward current evoked by a pulse to  50 mV and the outward current evoked by a pulse to 50 mV are labeled. (C) Conductance was deter-
mined from the equation gm   INa/(Em   ENa), where INA is the peak current, Em is the test voltage, and ENa is the estimated reversal poten-
tial, and plotted against the corresponding voltage. Plots were ﬁtted with a Boltzmann function. The average midpoint voltage (V0.5) and
slope (k) of the function for control Nav1.4 wild-type (circle, n   5) were (in mV)  30.8   1.1 and 9.9   0.9, respectively, and  30.4   1.4
and 8.2   1.3 for the ﬂecainide treated cell (triangle, n   4). The holding potential was  140 mV. The  1 subunit was cotransfected with
rNav1.4.T
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tronics), ﬁltered at 3 kHz, collected, and analyzed with pClamp8
software (Axon Instruments, Inc.). Holding potential was set at
 
 
 
140 mV. Leak and capacitance were subtracted by the patch
clamp device and further by the leak subtraction protocol (P/
 
 
 
4).
Voltage error was 
 
 
 
4 mV after series resistance compensation. An
unpaired Student’s 
 
t
 
 test was used to evaluate estimated parame-
ters (mean 
 
 
 
 SEM or ﬁtted value 
 
 
 
 SEM of the ﬁt); P values of
 
 
 
0.05 were considered statistically signiﬁcant.
 
RESULTS
 
Families of rNav1.4 Na
 
 
 
 Currents Before and 
After Flecainide Treatment
 
Families of superimposed Na
 
 
 
 currents at voltages
ranging from 
 
 
 
120 to 
 
 
 
50 mV were recorded before
drug application (Fig. 1 A). Subsequently, ﬂecainide at
30 
 
 
 
M was applied externally and Na
 
 
 
 currents were
monitored by test pulses (
 
 
 
30 mV for 5 ms) at a 30-s in-
terval. About 50% of the peak currents were inhibited
after ﬂecainide block reached its steady-state, which
was usually within 5–7 min. The Na
 
 
 
 current family in
30  M ﬂecainide was then recorded (Fig. 1 B). The
current kinetics remained unchanged, and the conduc-
tance/voltage curves remained comparable with or
without ﬂecainide (Fig. 1 C).
Flecainide Block of Na  Channels at Various Voltages
We applied a voltage-scanning protocol ranging from
 180 to  10 mV to determine whether distinct high-
afﬁnity binding of ﬂecainide exists in rNav1.4 Na  chan-
nels. This pulse protocol consisted of a conditioning
pulse at various voltages, with a 10-s duration intended
for drug binding. The 10-s duration was selected be-
cause longer duration would elicit greater Na -channel
slow inactivation, particularly at the more positive volt-
ages (Fig. 2 A, open circles). Pulses were applied at 30-s
intervals. This protocol was originally used to test if in-
activated channels have higher afﬁnities than resting
channels for local anesthetics (Wright et al., 1997,
1999). Fig. 2 A (closed circles) shows that ﬂecainide at
30  M blocks a constant level ( 50%) at hyperpolariz-
ing potentials from  180 to  100 mV. The block in-
creases continuously from  80 to  10 mV when nor-
malized with the control current at each voltage. This
voltage dependence of ﬂecainide block in rNav1.4 at
the depolarized voltages differed signiﬁcantly from that
of LAs, which reached a constant level around  60 mV
(Wright et al., 1997, 1999). This result suggests that
ﬂecainide does not have access to the fast-inactivated
Na  channels as readily as traditional LAs. Such a result
is consistent with the report by Liu et al. (2003), who
found that ionized ﬂecainide (pKa 9.3, 99% charged at
pH7.4) gains access to its receptor via an intracellular
pathway primarily after channels open.
To determine the IC50 value directly, we then mea-
sured the dose–response curve of ﬂecainide with a 10-s
conditioning pulse at  160,  70, and  20 mV. Fig. 2 B
shows the results from these measurements at  20,
 70, and  160 mV with IC50 values of 13.3   0.3,
21.2   0.4, and 31.9   3.0  M, respectively. The differ-
ence in ﬂecainide afﬁnities at these voltages is less
than threefold, conﬁrming the voltage-scanning results
Figure 2. (A) Voltage dependence of ﬂecainide block in rNav1.4
channels. Conditioning prepulses ranging from  180 mV to  10
mV were applied for 10 s. After a 100-ms interval at  140 mV, Na 
currents were evoked by a test pulse at 30 mV for 5-ms. Currents
recorded before (open circle, n   6) and after 30  M ﬂecainide
(closed circle, n   6) were normalized to the current obtained at
the  180 mV conditioning pulse and plotted against the condi-
tioning voltages. Flecainide data were then renormalized at each
voltage with respect to the control value without ﬂecainide. Data
were ﬁtted with a Boltzmann function (1/[1   exp((V0.5   V)/
kE)]). The average V0.5 value and kE (slope factor) value for the ﬁt-
ted functions were (in mV)  47.9   1.1 and 8.6   0.9, respec-
tively, for control and  57.3   2.7 and 17.6   2.1, respectively, for
ﬂecainide. (B) Dose–response curves for ﬂecainide block. Pulse
protocols were the same as in (A) with a conditioning pulse to
 20,  70, or  160 mV. The peak amplitudes of Na  current were
measured at various ﬂecainide concentrations, normalized to the
peak amplitude of the control, and plotted against drug concen-
tration. Solid lines represent ﬁts to the data with the Hill equation.
IC50 values (mean   SEM) and Hill coefﬁcients (mean   SEM; in
brackets) for Epp    20 mV (triangle, n   5),  70 mV (circle, n  
6), and  160 mV (square, n   5) are 13.3   0.3  M (1.17   0.03),
21.2   0.4  M (1.14   0.02), and 31.9   3.0 (1.27   0.12), respec-
tively. Pulses were delivered at 30-s intervals.T
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shown in Fig. 2 A. In comparison, the difference be-
tween the resting and inactivated block is 28-fold for
the LA cocaine under identical conditions (250  M vs.
9  M; Wright et al., 1997).
Development of and Recovery from Flecainide Block
One possible explanation for the shallow voltage de-
pendence of ﬂecainide block shown in Fig. 2 A is that
the inactivated channels interact with the drug rather
slowly. This appeared to be the case, as shown in Fig. 3
A, for the development of the inactivated block at  50
mV. We chose  50 mV because steady-state inactivation
reached its completion within 100 ms (h∞   0; unpub-
lished data). The time constant was measured 7.9   0.7 s.
Once developed either at  50 mV or at  30, the re-
covery from block at 100  M ﬂecainide was extremely
slow, with a time constant of 273   14 s (Fig. 3 B, closed
circle) or 225   12 s (Fig. 3 C, closed circle), respec-
tively, as if ﬂecainide was trapped within the channel.
Despite our best efforts, we could not ascertain that
these recovery time courses reached their plateau as
these experiments would take too long to complete.
Unexpectedly, the amplitude of the Na  currents con-
tinued to increase during this recovery period. Its am-
plitude exceeded the current amplitude before the
conditioning pulse ( 20% of control; Fig. 3 B) and
reached a level that was 78.5   4.9% (n   9; open tri-
angle) of the control amplitude without ﬂecainide.
Thus, block by ﬂecainide under these two conditions
recovered nearly to a level  80% of the control value if
cells were not stimulated for 17 min. These results indi-
cated that the resting block at  140 mV by ﬂecainide is
much less than the block we normally monitored at the
30-s interval. The estimated IC50 for the resting block of
ﬂecainide in wild-type channels is 365  M at  140 mV
using the Langmuir isotherm. The IC50 results in Fig. 2
B therefore include the background ﬂecainide block,
which failed to recover during the 30-s pulse interval.
Background Flecainide Block of Na  Channels when 
Stimulated at Low Frequencies
To conﬁrm that background ﬂecainide block indeed
occurs during the 30-s pulse interval, we varied the in-
terval duration from 5 to 120 s. Flecainide at 100  M
produced very different degrees of block at intervals of
5, 15, 30, 60, and 120 s (Fig. 4); the steady-state block at
these frequencies was 87.5%, 82.1%, 81.1%, 70.1%,
and 52.5%, respectively. These values are close to the
estimated values based on the recovery time course
(Fig. 3 C), which yielded 88%, 84%, 78%, 68%, and
54%, respectively. Thus, even with the application of
monitoring pulses at very low frequencies, the back-
ground block of Na  currents by ﬂecainide is signiﬁ-
cant as compared with those by traditional LAs because
of the extremely slow recovery of ﬂecainide block (Fig.
3, B and C).
Figure 3. Development of and recovery from ﬂecainide block in rNav1.4 wild-type channels by 100  M ﬂecainide. (A) For the develop-
ment of inactivated block, the prepulse duration was varied at  50 mV. The peak current was measured at 30 mV after a 100-ms interval at
 140 mV, normalized to the initial peak amplitude (t   0), and then plotted against the prepulse duration. The data were ﬁtted by a sin-
gle-exponential function. The time constant (and ﬁnal y0 values) for ﬂecainide block (closed circle, n   5) was 7.9   0.7 s (20.9   3.2%),
respectively. Recovery from 100 M ﬂecainide block at  50 mV for 10 s (B) and at  30 mV for 10 s (C) were measured after a variable re-
covery interval at  140 mV. A 5-ms test pulse at 30 mV was used to evoke available currents. The recovery time course for control (open
circle) and for ﬂecainide (closed circle) were normalized and ﬁtted by the sum of two exponentials. Slow time constants of 273.4   14.3 s
and 225.1   12.1 represented the recovery from ﬂecainide block at  50 mV (B, closed circle; n   5, 72.8%) and at 30 mV (C, closed cir-
cle; n   5, 68.3%), respectively. The ﬂecainide data in B and C were renormalized by the peak current amplitude without drug. After rest-
ing for 1,000 s, the peak currents reached to  80% of the control level (open triangle).T
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Inactivation-deﬁcient Na  Current Families Before and 
After Flecainide Treatment
It is unclear whether ﬂecainide directly blocks open
channels, because the channel opens once during
depolarization, lasts for  0.5 ms, and is then inacti-
vated (Aldrich et al., 1983). To determine direct interac-
tions between ﬂecainide and the open state, we chose
to study inactivation-deﬁcient rNav1.4-L435W/L437C/
A438W mutant channels (Wang et al., 2003). This mu-
tant channel inactivated minimally during depolariza-
tion; as a result, a substantial fraction of peak current
was maintained. Fig. 5, A and B, shows superimposed
Na  current families before and after ﬂecainide at 30
 M. A strong time-dependent block of the outward
maintained Na  currents occurred even within the
5-ms test duration. Therefore, this result provides the
direct evidence that ﬂecainide binds readily with the open
state of the Na  channel and suggests that this mu-
tant can be used as a tool for detailed studies on
ﬂecainide block. The conductance/voltage relation-
ship of inactivation-deﬁcient mutant channels shows
that activation and the slope factor were not changed
signiﬁcantly before and after treatment with 30  M
ﬂecainide.
Dose–response Curve of Flecainide Block in
Inactivation-deﬁcient Na  Channels
We generated persistent late Na  currents with a test
pulse of  30 mV for 140 ms and then measured the
time-dependent block of ﬂecainide at various concen-
trations (Fig. 6 A). We then constructed the dose–
response curve of ﬂecainide block of inactivation-deﬁ-
cient Na  channels (Fig. 6 B). The IC50 values for the
open (estimated block at the end of the pulse; open cir-
cle) and the resting block at  140 mV (estimated block
at the peak current; open triangle) were 0.61   0.07
 M and 306.9   19.3  M, respectively. In comparison,
with a conditioning pulse near activation threshold at
 50 mV for 10 s, the IC50 was 4.1   0.1  M (open
square) or about sevenfold less potent than that of the
open-channel block. The pulse duration of 10 s was ap-
plied since the development of this threshold block
had a time constant of 1.38   0.32 s (n   5). This sug-
gests channel opening is required for the high-afﬁnity
block of ﬂecainide. With limited channel opening
Figure 4. Use-dependent block by 100  M ﬂecainide at low
stimulus frequencies. Brief test pulses to 30 mV for 5 ms were used
to evoke Na  current at intervals of 5 s (n   5), 15 s (n   6), 30 s
(n   5), 60 s (n   5), and 120 s (n   5). Peak current of the test
pulse was measured and normalized to the initial peak amplitude
before ﬂecainide application. Data was plotted against the time af-
ter drug exposure. The remaining peak currents (y0) were esti-
mated to be 12.5% (5-s interval), 17.9% (15 s), 18.9% (30 s),
29.9% (60 s), and 47.5% (120 s).
Figure 5. Inactivation-deﬁcient rNav1.4-L435W/L437C/A438W Na  currents before and after application of 30  M ﬂecainide. Super-
imposed current traces before (A) and after ﬂecainide (B) were evoked by 5-ms pulses ranging from  120 to  50 mV in 10-mV incre-
ments. The inward current evoked by a pulse to  50 mV and the outward current evoked by a pulse to  50 mV are labeled. (C) Normal-
ized conductance (gm) plotted versus the amplitude of the 5-ms voltage step. Gm was determined as described in Fig. 1 C. Plots were ﬁtted
with a Boltzmann function. The average midpoint voltage (V0.5) and slope (k) of the function in the control solution (open square, n   5)
were  20.2   1.6 and 11.1   1.4, respectively, and  20.2   1.3 and 13.8   1.2 for the ﬂecainide-treated cell (closed square, n   5).T
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around activation threshold, the ﬂecainide afﬁnity is
not as high as that of the open-channel block. The de-
cay phase of Na  currents shown in Fig. 6 A after drug
applications could be well ﬁtted with a single exponen-
tial function. We calculated the inverse of the time con-
stant ( ) and plotted against the corresponding con-
centration (Fig. 6 C). We estimated the on-rate and
off-rate constant of ﬂecainide with the open channel
to be 14.9  M 1s 1 (the slope) and 12.2 s 1 (y-inter-
cept), respectively, as described by O’Leary and Cha-
hine (2002). The calculated dissociation constant (KD)
yields 0.82  M.
Use-dependent Block of Wild-type and Inactivation-deﬁcient 
Na  Currents by Flecainide at 5 Hz
The repetitive pulses of 30 mV at 5 Hz for 60 pulses
elicit additional use-dependent block of 100  M ﬂecain-
ide by  45% in wild-type Na  currents (Fig. 7 A). In
comparison with inactivation-deﬁcient mutant chan-
nels, the use-dependent block by 10  M ﬂecainide de-
veloped rapidly after the ﬁrst depolarization (Fig. 7 B,
closed circles). It appeared that this rapid phase of
the use-dependent block was caused directly by the
time-dependent block of the noninactivating current
during the pulse (Fig. 6 A, 10  M). There was also a
slow inhibition of peak currents during repetitive
pulses in inactivation-deﬁcient channels even without
ﬂecainide (Fig. 7 B, open circles); this decrease in peak
current amplitude is likely due to the enhanced slow in-
activation in this mutant (Wang et al., 2003).
Recovery from the Open-channel Block of Flecainide in 
Inactivation-deﬁcient Mutant Channels
We measured the recovery time course of the open-
channel block by ﬂecainide once developed in the in-
activation-deﬁcient mutant channels. At the activation
threshold of  50 mV for 100 ms, few channels were
blocked by 10  M ﬂecainide (Fig. 8 A). In contrast,
 90% of inactivation-deﬁcient Na  channels were
blocked by 10  M ﬂecainide at 30 mV for 100-ms (Fig.
8 B, closed circle). After the open-channel block devel-
oped, the current recovered with a time constant of
11.2 s   0.7 (n   5; solid line). In comparison, this re-
covery time constant of the inactivation-deﬁcient mu-
tant channels is 20-fold faster than that of the wild-type
channels (Fig. 3 C). With this recovery time course,
ﬂecainide will produce  10% background block when
the cell is stimulated at 1 per 30 s. In contrast, when the
cell is stimulated at 5 Hz, ﬂecainide will produce addi-
tional rapid use-dependent block of peak currents,
since channels remain blocked during repetitive pulses
with a 200-ms interval (5 Hz) (Fig. 7).
DISCUSSION
We examined the state-dependent block of ﬂecainide
in rNav1.4 wild-type and inactivation-deﬁcient L435W/
Figure 6. Block of inactivation-deﬁcient Nav1.4 L435W/L437C/A438W channels at various ﬂecainide concentrations. (A) Superim-
posed Na  currents evoked by a 140-ms test pulse to 30 mV every 30 s were shown at various ﬂecainide concentrations. Steady-state block at
each concentration was achieved within 5 min. (B) Dose–response curves were constructed for open-channel block (relative steady-state
block at end of 140 ms test pulse in A; open circle), resting block (relative block of peak current in A; open triangle), and threshold block
at  50 mV (open square). All pulses were delivered at 30-s intervals. For threshold block, a conditioning pulse at  50 mV for 10 s followed
by a 100-ms interpulse at  140 mV before the test pulse. The peak amplitudes of Na  currents were measured at various ﬂecainide con-
centrations, normalized to the peak amplitude of the control, and plotted against drug concentration. Solid lines represent ﬁts to the data
with the Hill equation. IC50 values (mean   SEM) and Hill coefﬁcients (mean   SEM; in parentheses) are 0.61   0.07 (1.06   0.12) for
open-channel block (circle, n   7), 4.08   0.11 (1.18   0.03) for Epp    50 mV (square, n   5), 306.9   19.3 (1.30   0.10) for resting
block (triangle, n   5, renormalized). Renormalization for resting block was performed to correct a small background block ( 10%) by
monitoring pulses with 30-s intervals. The decay phase of the Na  current in A was ﬁtted with a single exponential function, and the corre-
sponding time constant ( ) was inverted and plotted against the corresponding concentration (C). Data were ﬁtted with a linear regres-
sion y   14.9x   12.16 (solid line). On-rate (kon) corresponded to the slope of the ﬁtted line (14.9  M 1s 1) and the off-rate (koff) corre-
sponded to the y-intercept (12.16 s 1). The equilibrium dissociation constant was determined by the equation KD   koff/kon and equaled
0.81  M.T
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L437C/A438W mutant Na  channels. There are three
novel ﬁndings. First, pulse protocols that activate Na 
channels at frequencies even as low as one per 120 s sig-
niﬁcantly perturb the degree of ﬂecainide block and
induce a signiﬁcant “background” block of Na  cur-
rents. This background block, which developed after
Na  channel activation, has a very slow recovery time
course, with a time constant over 225 s at  140 mV.
Second, the resting- and open-channel afﬁnities differ
by 500-fold in the inactivation-deﬁcient mutant chan-
nels (0.61  M vs. 307  M, respectively). This IC50 value
for ﬂecainide open-channel block is within the thera-
peutic plasma concentration range of 0.4 to 2.0  M
(Roden, 2001). Hill coefﬁcients of these measurements
were near unity, indicating that there is one ﬂecainide
receptor per mutant channel. Third, the recovery from
the open-channel block by ﬂecainide in inactivation-
deﬁcient mutant channels is relatively fast at  140 mV,
with a time constant of 11.2 s, or  20-fold faster than
that in wild-type Na  channels with intact fast inactiva-
tion. The signiﬁcance of these new ﬁndings is discussed
as follows.
Resting Block by Flecainide Is Rather Weak
The interaction of ﬂecainide with the resting Na 
channels appears to be weak. Flecainide at 100  M
blocks only 22.5% (n   9) of peak Na  currents when
the cell is held at  140 mV and is not stimulated in
1,000 s with drug present (Fig. 3, B and C). The calcu-
lated IC50 for ﬂecainide block is 365  M using the
Langmuir isotherm. It was time consuming to measure
the resting block of ﬂecainide since only one test pulse
per  17 min could be applied. The true IC50 value for
ﬂecainide-resting block could be even larger if the
block produced by the monitoring pulse did not re-
cover fully during the time of measurement (at 1,000 s).
In contrast, the IC50 for ﬂecainide block of inactivation-
deﬁcient mutant Na  channels can be estimated by the
dose–response curve readily from the peak current am-
plitude (Fig. 6), which yields 307   19  M for ﬂecain-
ide resting block (n   5). Thus, the resting ﬂecainide
afﬁnity in inactivation-deﬁcient mutant channels is sim-
ilar to that in wild-type.
Our estimated IC50 values for ﬂecainide-resting block
of rNav1.4 wild-type and inactivation-deﬁcient Na 
channels deviate signiﬁcantly from previous reports.
For example, Nagatomo et al. (2000) reported IC50 val-
ues of 127 and 80  M for hH1 wild-type and  KPQ mu-
tant channels for ﬂecainide-resting block. Our dose–
response curve (Fig. 2 B) shows that the apparent IC50
value at  160 mV is  31.9   2.8  M when measured
with a 30-s interval between monitoring pulses. This
value is off by 10-fold from that of the ﬂecainide resting
afﬁnity (365  M). The difference arises because  20%
of ﬂecainide block produced by monitoring pulses re-
covered during the 30-s interval (Fig. 3 C). This unusu-
ally slow recovery from the use-dependent block of
ﬂecainide with a time constant over 225 s (Fig. 3, B and
C) differs greatly from that of a long-acting LA, S( )-
bupivacaine, which recovers with a time constant of 4.4 s
in cardiac Na  channels (Valenzuela et al., 1995).
Flecainide Preferentially Blocks the Open State
of the Na  Channel
Repetitive pulses at 5 Hz elicit additional ﬂecainide
block of Na  currents (Fig. 7). This use-dependent
phenotype at high frequencies is well documented for
ﬂecainide block (Nitta, et al., 1992). Since Na  chan-
nels open only once for  0.5 ms during channel activa-
Figure 7. Use-dependent block by ﬂecainide in wild-type and in-
activation-deﬁcient mutant channels at a high frequency. Repeti-
tive pulses to  30 mV for 24 ms were delivered at 5 Hz. (A) The
wild-type peak amplitude of each dataset was normalized to the
ﬁrst pulse of the set and plotted against the pulse number. In con-
trol solution, the pulse protocol did not elicit a use-dependent re-
duction in current amplitude. Data were best ﬁt by a single expo-
nential function for 100  M ﬂecainide (closed circle, n   5) with a
time constant of 2.5   0.1 pulses with 54.8   0.1% remaining cur-
rent. (B) Use-dependent block of Nav1.4 L435W/L437C/A438W
by 10  M ﬂecainide was measured at 5Hz. The time constant for
control solution (open circle, n   6) was 20.4   0.4 pulses. This
current reduction was probably caused by the enhanced slow inac-
tivation in these mutant channels. The time constant for 10  M
ﬂecainide (closed circle, n   5) was too fast to be measured accu-
rately. Steady-state was reached at 33.1   0.1% remaining current.T
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tion (Aldrich et al., 1983), it is unclear whether ﬂecain-
ide blocks the open state of the wild-type channel di-
rectly. In fact, Liu et al. (2002) recently suggested that
use-dependent block requires channel opening but is
not likely due to open-channel block. Rather, ﬂecain-
ide appears to interact with inactivated states that fol-
low depolarization-induced channel opening.
Our results from the inactivation-deﬁcient Na  chan-
nels, however, illustrate that use-dependent block is
due primarily to open-channel block. Three pieces of
evidence support this notion. First, ﬂecainide blocks
the late open Na  channel rapidly and potently (Fig.
5). The IC50 of ﬂecainide block of the open state is 0.61
 M at 30 mV, and its on-rate and off-rate constants are
14.9   M 1s 1 and 12.2 s 1, respectively. This on-rate
value is comparable to those of bupivacaine (Valenzu-
ela et al., 1995; 7  M 1s 1) and cocaine (O’Leary and
Chahine, 2002; 6.8  M 1s 1). With these on-rate val-
ues, both LAs and ﬂecainide will block a limited frac-
tion of peak Na  currents, as demonstrated by mathe-
matical modeling (Valenzuela et al., 1995), but will in
time block most of persistent late Na  currents even at
the low concentration of 3  M (Fig. 6 A). Second, the
time course of ﬂecainide block of the wild-type–inacti-
vated Na  channel is relatively slow (Fig. 3 A), with a
time constant of 7.9 s at  50 mV. This slow rate of bind-
ing between ﬂecainide and the inactivated state likely
limits the contribution of the inactivated block during
repetitive pulses of a short duration (24 ms; Fig. 8 A).
Third, there is no apparent high-afﬁnity ﬂecainide
block at  50 mV for the inactivated state of Na  chan-
nels (Fig. 2) as normally found for traditional LAs
(Wright et al., 1997, 1999). On the basis of these data,
we propose that ﬂecainide is primarily an open-chan-
nel blocker with minimal interactions with the resting
state. However, it remains unclear whether upon
ﬂecainide binding the conformation of the open chan-
nel can subsequently assume the “inactivated confor-
mation” where the inactivation gate may close but may
not bind strongly to its receptor in inactivation-deﬁ-
cient mutant channels.
Does Fast Inactivation Stabilize Flecainide Binding?
As noted above, the recovery from ﬂecainide block af-
ter channel activation is very slow at  140 mV for the
wild-type, with a time constant  225 s. In contrast, inac-
tivation-deﬁcient mutant channels display a much
faster recovery time course of ﬂecainide block, with a
time constant of 11.2 s at the holding potential of  140
mV. What causes this difference in the ﬂecainide disso-
ciation rate? It is unlikely that slow inactivation plays a
prominent role in this difference, since the inactiva-
tion-deﬁcient mutant channels display an enhanced
slow inactivation (Wang et al., 2003) and yet ﬂecainide
dissociates faster from these channels than it does from
the wild-type upon repolarization. One simple interpre-
tation for the slow recovery phenotype in wild-type is
that the inactivation gate may stabilize ﬂecainide bind-
ing. McPhee et al. (1994, 1995) and Yarov-Yarovoy et al.
(2002) previously suggested that the inactivation gate
enters the Na  permeation pathway and interacts with
its docking site at S6 COOH termini. Their model also
explains the phenotype of our inactivation-deﬁcient
Na  channels with COOH-terminal mutations at D1S6
(L435W/L437C/A438W) (Wang et al., 2003). Such a
Figure 8. Recovery from
the ﬂecainide open-channel
block at  140 mV. (A) A con-
ditioning pulse of  50 mV
for 100 ms was applied and
the recovery of ﬂecainide
block was measured with vari-
ous intervals at  140 mV (in-
set). Notice that less than
15% of currents recovered
slowly in the presence of 10
 M ﬂecainide (closed circle)
with a time constant of 13.1  
2.7 s (n   5). (B) With a con-
ditioning pulse of 30 mV for
100 ms,  80% of currents re-
covered slowly in the pres-
ence of 10  M ﬂecainide
(closed circle), with a time
constant of 11.2   0.9 s (n  
5; solid line). For comparison purpose with the wild-type, we primarily used this single exponential function in our report. However, this
recovery time course could be better ﬁtted with a two-exponential function (dotted line) with  1   3.1   0.7 s (31.0   6.9%) and  2   19.3  
3.0 s (55.9   6.6%). The reason for this phenomenon is unclear but may be due to multiple opening modes in inactivation-deﬁcient Na 
channels.T
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docking site could be situated adjacent to the ﬂecain-
ide receptor at D4S6 (Ragsdale et al., 1996). If true, the
ﬂecainide-receptor complex may be stabilized in situ by
the inactivation gate directly. This interpretation seems
also consistent with the modulated receptor hypothesis
for the complicated action of LAs and antiarrhythmic
agents on Na  channels (Hille, 1977; Hondeghem and
Katzung, 1977). It is noteworthy that Vedantham and
Cannon (1999) reported no effect of lidocaine on the
apparent rate of recovery of lidocaine-blocked Na 
channel from fast inactivation. This phenomenon may
be due to differences among various therapeutic Na 
channel blockers in their access and mode of block as
suggested by Grant et al. (2000).
Alternatively, the ﬂecainide receptor may be altered
signiﬁcantly by mutations in the inactivation-deﬁcient
mutant channel (rNav1.4-L435W/L437C/A438W) and
its afﬁnity for ﬂecainide may be reduced drastically so
that ﬂecainide dissociated rapidly from its receptor.
This possibility is less likely, since the IC50 for the open
state in the inactivation-deﬁcient mutant channel is
0.61  M at 30 mV, suggesting that ﬂecainide binds to
its receptor with a high afﬁnity. This potency is far
greater than that previously reported for ﬂecainide in
wild-type channels. Nitta et al. (1992) reported a KD of
7  M for the use-dependent block of ﬂecainide at 2.5
Hz. This value still differs  10-fold from that for inacti-
vation-deﬁcient mutant channels reported here. The
higher apparent KD value of ﬂecainide in wild-type Na 
channels is likely due to their short open time ( 0.5
ms), which limits ﬂecainide access to its receptor. It is
unlikely that these high KD values are inherent for the
cardiac Na  channel isoform, since our preliminary re-
sults indicate that ﬂecainide also blocks homologous
inactivation-deﬁcient hNav1.5 cardiac Na  channels
with similar potency (IC50   0.66  M).
Physiological Signiﬁcance of Flecainide
as an Open-channel Blocker
Flecainide appears to be beneﬁcial for patients with de-
fective Na  channels in skeletal muscle (Rosenfeld et
al., 1997) and in heart (Windle et al., 2001). Many de-
fective mutant channels exhibit persistent late Na  cur-
rents, such as in the cases of LQT- KPQ (Bennett et al.,
1995), hyperkalemic periodic paralysis (Cannon and
Strittmatter, 1993), or painful congenital myotonia
(Wang et al., 1999). In general, the probability of the
defective Na  channel entering the noninactivating
mode of gating is  5%. It is noteworthy that persistent
late Na  currents with multiple gating modes are
present in the wild-type channels (Patlak and Ortiz,
1985, 1986), although the probability ( 0.1%) is far
less than that in defective mutant channels.
Could ﬂecainide block late persistent Na  currents
for its efﬁcacy described above? This is possible since
ﬂecainide indeed blocks effectively and rapidly the
open state of the inactivation-deﬁcient mutant chan-
nels, as shown in this report. The therapeutic plasma
concentration of ﬂecainide is in the range of 0.4–2  M
(0.2–1   g/ml) (Roden, 2001; Viswanathan et al.,
2001). A substantial fraction of persistent late currents
should be blocked by ﬂecainide at this concentration
range, based on an IC50 value of 0.61  M. Persistent
Na  currents will be particularly susceptible for block
because ﬂecainide gains access to its receptor readily
during channel opening (Fig. 7 A) and during repeti-
tive pulses (Fig. 8). Hence, it is feasible that ﬂecainide
primarily targets persistent late Na  currents for its
therapeutic action but spares most of initial peak cur-
rents, which inactivate rapidly. Caution should be taken
in extrapolating the IC50 values to the clinical setting,
since several factors also could affect the in vivo po-
tency of ﬂecainide (Nagatomo et al., 2000). These in-
clude the body temperature, additional   subunits
present, posttranslational modiﬁcations of Na  chan-
nels, multiple gating modes of late Na  currents, and
ﬂecainide block of other ion channels. Finally, ﬂecain-
ide as an antiarrhythmic agent could become proar-
rhythmic at a higher pacing frequency and at a higher
concentration, as the block of the initial peak currents
will accumulate continuously due to its slow recovery.
Novel open-channel blockers with a faster recovery
time may lessen their proarrhythmic propensity and
ﬁnd broad applications for various pathological condi-
tions that manifest an increase of persistent late Na 
currents in skeletal muscle (Cannon, 1996), in heart
(Saint et al., 1992), and in brain (Crill, 1996).
This work was supported by National Institutes of Health
(GM48090 and HL66076).
Olaf S. Andersen served as editor.
Submitted: 29 April 2003
Accepted: 24 July 2003
REFERENCES
Aldrich, R.W., D.P. Corey, and C.F. Stevens. 1983. A reinterpreta-
tion of mammalian sodium channel gating based on single chan-
nel recording. Nature. 306:436–441.
Anno, T., and L.M. Hondeghem. 1990. Interactions of ﬂecainide
with guinea pig cardiac sodium channels. Circ. Res. 66:789–803.
Bennett, P.B., K. Yazawa, N. Makita, and A.L. George. 1995. Molec-
ular mechanism for an inherited cardiac arrhythmia. Nature. 376:
683–685.
Cannon, S.C. 1996. Sodium channel defects in myotonia and peri-
odic paralysis. Annu. Rev. Neurosci. 19:141–164.
Cannon, S.C., and S.M. Strittmatter. 1993. Functional expression of
sodium channel mutations identiﬁed in families with periodic
paralysis. Neuron. 10:317–326.
Crill, W.E. 1996. Persistent sodium current in mammalian central
neurons. Annu. Rev. Physiol. 58:349–362.
Grant, A.O., R. Chandra, C. Keller, M. Carboni, and C.F. Starmer.
2000. Block of wild-type and inactivation-deﬁcient cardiac so-
dium channels IFM/QQQ stably expressed in mammalian cells.T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
G
e
n
e
r
a
l
 
P
h
y
s
i
o
l
o
g
y
374  Flecainide Block of Persistent Late Na  Currents
Biophys. J. 79:3019–3035.
Hamill, O.P., E. Marty, M.E. Neher, B. Sakmann, and F.J. Sigworth.
1981. Improved patch-clamp techniques for high-resolution cur-
rent recording from cells and cell-free membrane patches.
Pﬂugers Arch. 391:85–100.
Hille, B. 1977. Local anesthetics: hydrophilic and hydrophobic
pathways for the drug receptor reaction. J. Gen. Physiol. 69:497–
515.
Hondeghem, L.M., and B.G. Katzung. 1977. Time- and voltage-
dependent interactions of antiarrhythmic drugs with cardiac so-
dium channels. Biochim. Biophys. Acta. 472:373–398.
Liu, H., J. Atkins, and R.S. Kass. 2003. Common molecular determi-
nants of ﬂecainide and lidocaine block of heart na( ) channels:
evidence from experiments with neutral and quaternary ﬂecain-
ide analogues. J. Gen. Physiol. 121:199–214.
Liu, H., M. Tateyama, C.E. Clancy, H. Abriel, and R.S. Kass. 2002.
Channel opening are necessary but not sufﬁcient for use-depen-
dent block of cardiac Na  channels by ﬂecainide: evidence from
the analysis of disease-linked mutations. J. Gen. Physiol. 120:39–
51.
McPhee, J.C., D.S. Ragsdale, T. Scheuer, and W.A. Catterall. 1995. A
critical role for transmembrane segment IVS6 of the sodium
channel alpha subunit in fast inactivation. J. Biol. Chem. 270:
12025–12034.
McPhee, J.C., D.S. Ragsdale, T. Scheuer, and W.A. Catterall. 1994. A
mutation in segment IVS6 disrupts fast inactivation of sodium
channels. Proc. Natl. Acad. Sci. USA. 91:12346–12350.
Nagatomo, T., C.T. January, and J.C. Makielski. 2000. Preferential
block of late sodium currents in the LQT3  KPQ mutant by the
class I(c) antiarrhythmic ﬂecainide. Mol. Pharmacol. 57:101–107.
Nitta, J., A. Sunami, F. Marumo, and M. Hiraoka. 1992. States and
sites of actions of ﬂecainide on guinea-pig cardiac sodium chan-
nels. Eur. J. Pharmacol. 214:191–197.
O’Leary, M.E., and M. Chahine. 2002. Cocaine binds to a common
site on open and inactivated human heart (Nav1.5) sodium
channels. J. Physiol. 541:701–716.
Patlak, J., and M. Ortiz. 1985. Slow currents through single sodium
channels of adult rat heart. J. Gen. Physiol. 86:89–104.
Patlak, J., and M. Ortiz. 1986. Two modes of gating during late Na 
channel currents in frog sartorius muscle. J. Gen. Physiol. 87:305–
326.
Ragsdale, D.S., J.C. McPhee, T. Scheuer, and W.A. Catterall. 1996.
Common molecular determinants of local anesthetic, antiar-
rhythmic, and anticonvulsant block of voltage-gated Na  chan-
nels. Proc. Natl. Acad. Sci. USA. 93:9270–9275.
Roden, D.M. 2001. Antiarrhythmic drugs. In Goodman and Gil-
man’s The Pharmacological Basis of Therapeutics. J.G. Hard-
man, L.E. Limbird, P.B. Molinoff, R.W. Ruddon, and A.G. Gil-
man, editors. Macmillan Publishing Company, New York. 933–
970.
Rosenfeld, J., K. Sloan-Brown, and A.L. George. 1997. A novel mus-
cle sodium channel mutation causes painful congenital myoto-
nia. Ann. Neurol. 42:811–814.
Saint, D.A., Y.-K. Ju, and P.W. Gage. 1992. A persistent sodium cur-
rent in rat ventricular myocytes. J. Physiol. 453:219–231.
Valenzuela, C., D.J. Snyders, P.B. Bennett, J. Tamargo, and L.M.
Hondeghem. 1995. Stereoselective block of cardiac sodium
channels by bupivacaine in guinea pig ventricular myocytes. Cir-
culation. 92:3014–3024.
Vedantham, V., and S.C. Cannon. 1999. The position of the fast-
inactivation gate during lidocaine block of voltage-gated Na 
channels. J. Gen. Physiol. 113:7–16.
Viswanathan, P.C., C.R. Bezzina, A.L. George, D.M. Roden, A.A.
Wilde, and J.R. Balser. 2001. Gating-dependent mechanisms for
ﬂecainide action in SCN5A-linked arrhythmia syndromes. Circu-
lation. 104:1200–1205.
Wang, D.W., D. Van De Carr, P. Ruben, A.L. George, and P.B. Ben-
nett. 1999. Functional consequences of a domain 1/S6 segment
sodium channel mutation associated with painful congenital
myotonia. FEBS Lett. 448:231–234.
Wang, S.-Y., K. Bonner, C. Russell, and G.K. Wang. 2003. Tryp-
tophan scanning of D1S6 and D4S6 C-termini in voltage-gated
sodium channels. Biophys. J. 85:911–920.
West, J.W., D.E. Patton, T. Scheuer, Y. Wang, A.L. Goldin, and W.A.
Catterall. 1992. A cluster of hydrophobic amino acid residues re-
quired for fast Na  channel inactivation. Proc. Natl. Acad. Sci.
USA. 89:10910–10914.
Windle, J.R., R.C. Geletka, A.J. Moss, W. Zareba, and D.L. Atkins.
2001. Normalization of ventricular repolarization with ﬂecainide
in long QT syndrome patients with SCN5A:deltaKPQ mutation.
Ann. Noninvasive Electrocardiol. 6:153–158.
Wright, S.N., S.-Y. Wang, R.G. Kallen, and G.K. Wang. 1997. Differ-
ences in steady-state inactivation between Na channel isoforms
affect local anesthetic binding afﬁnity. Biophys. J. 73:779–788.
Wright, S.N., S.-Y. Wang, Y.-F. Xiao, and G.K. Wang. 1999. State-
dependent cocaine block of sodium channel isoforms, chimeras,
and channels coexpressed with  -subunits. Biophys. J. 76:233–245.
Yarov-Yarovoy, V., J.C. McPhee, D. Idsvoog, C. Pate, T. Scheuer, and
W.A. Catterall. 2002. Role of amino acid residues in transmem-
brane segments IS6 and IIS6 of the Na1 channel a-subunit in
voltage-dependent gating and drug block. J. Biol. Chem. 277:
35393–35401.